HLS Stock Overview
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia.
Healius Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$3.36|
|52 Week High||AU$5.54|
|52 Week Low||AU$3.36|
|1 Month Change||-11.58%|
|3 Month Change||-9.92%|
|1 Year Change||-31.85%|
|3 Year Change||4.35%|
|5 Year Change||9.09%|
|Change since IPO||140.00%|
Recent News & Updates
|HLS||AU Healthcare||AU Market|
Return vs Industry: HLS underperformed the Australian Healthcare industry which returned -20.7% over the past year.
Return vs Market: HLS underperformed the Australian Market which returned -11% over the past year.
|HLS Average Weekly Movement||3.6%|
|Healthcare Industry Average Movement||5.2%|
|Market Average Movement||9.6%|
|10% most volatile stocks in AU Market||16.9%|
|10% least volatile stocks in AU Market||4.3%|
Stable Share Price: HLS is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: HLS's weekly volatility (4%) has been stable over the past year.
About the Company
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.
Healius Limited Fundamentals Summary
|HLS fundamental statistics|
Is HLS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HLS income statement (TTM)|
|Cost of Revenue||AU$1.33b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.51|
|Net Profit Margin||12.58%|
How did HLS perform over the long term?See historical performance and comparison